Synovus Financial Corp Moderna, Inc. Transaction History

Synovus Financial Corp

$7.52 Billion
Q2 2024

A detailed history of Synovus Financial Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 2,068 shares of MRNA stock, worth $135,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,068

Previous 2,439 15.21%

Holding current value

$135,971

Previous $259,000 5.41%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $37,548 - $61,812	-371 Reduced 15.21%	2,068 $245,000
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $208,217 - $281,558	2,439 New	2,439 $259,000
Q4 2022 Feb 06, 2023	SELL	$118.38 - $210.04 $332,055 - $589,162	-2,805 Reduced 69.43%	1,235 $221,000
Q3 2022 Oct 27, 2022	SELL	$118.07 - $194.18 $27,156 - $44,661	-230 Reduced 5.39%	4,040 $476,000
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $25,885 - $39,026	221 Added 5.46%	4,270 $612,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $37,938 - $70,515	300 Added 8.0%	4,049 $704,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $19,420 - $31,691	-86 Reduced 2.24%	3,749 $959,000
Q3 2021 Nov 08, 2021	SELL	$221.9 - $484.47 $52,146 - $113,850	-235 Reduced 5.77%	3,835 $1.48 Million
Q2 2021 Aug 11, 2021	SELL	$129.91 - $234.98 $129,130 - $233,570	-994 Reduced 19.63%	4,070 $950,000
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $85,815 - $146,180	786 Added 18.37%	5,064 $664,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $53,841 - $139,115	819 Added 23.68%	4,278 $444,000
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $9,618 - $16,788	177 Added 5.39%	3,459 $244,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $91,442 - $246,560	3,082 Added 1541.0%	3,282 $210,000
Q1 2020 Apr 24, 2020	BUY	$17.78 - $31.58 $3,556 - $6,316	200 New	200 $6,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Moderna, Inc. Transaction History